The pharmaceutical leader has established itself as the leader in the fast-growing weight loss market. And although many ...
Zacks Investment Research on MSN
3 cancer stocks to buy amid rapid advances in cancer treatment
An updated edition of the October 28, 2025, article. The global oncology market is entering a period of significant evolution, supported by rising cancer incidence and rapid scientific advancement.
A routine blood test identified abnormalities, leading to follow-up tests. A hematologist diagnosed Evans with early-stage ...
Eli Lilly and Company today announced positive topline results from the ATTAIN-MAINTAIN trial. The Phase 3 study evaluated orforglipron, an investigational, once-daily oral small molecule ...
In this video, Matthew S. Davids, MD, said data from the BRUIN-313 trial supports front-line approval of pirtobrutinib in patients with previously untreated chronic lymphocytic leukemia or small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback